Erlotinib FDA approval date

The FDA approved Erlotinib (Tarceva) on 18 Nov 2004.

FDA approval date
18 Nov 2004

Drug identity checked against registry records

Also recorded as Tarceva

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2004-11-18DayErlotinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021743", "applicant_as_listed_by_fda": "OSI PHARMS", "brand_names": ["TARCEVA"], "active_ingredients": ["ERLOTINIB HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20041118", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026